Five deaths and 223 new cases of COVID-19 were reported on Thursday, along with 232 recoveries.

One of the residents who tested positive for COVID-19 and died was in their 60's from the far northeast, two were in their 70's from the far northeast and north-central zone, and two were in the 80+ age group from the northwest and Regina zones.

Of the new cases, 17 are in the south-central zone, 71 are in Saskatoon, 28 in the central-east, 24 in Regina, 15 in the southeast, 15 in the northwest, 12 in the north-central zone, nine in the far northeast, eight in the central-west, seven in the far northwest, six in the northeast, and five are in the southwest. Six new cases are pending resident information, and 30 new cases tested outside of the province were added to the following zones: Far North West, 5; Far North East, 10; North West, 4; North East, 1; Central West, 1; Central East, 1; Saskatoon, 4; and Regina, 4.

2,032 cases are considered active, with 77 of those located in the sub-region 'south-central 2' which is made up of Moose Jaw and the surrounding area.

161 people are in hospital with 126 receiving inpatient care, and 35 are in intensive care.

Vaccine Update

Vaccination bookings open up Friday to all residents aged 23 and up, just in time for a walk-in clinic that will be opening Saturday at the Moose Jaw Exhibition Grounds.

The clinic will be open from 8:30 to 5 and does not require an appointment.

An additional 8,415 doses of COVID-19 vaccine have been given in Saskatchewan, bringing the total number of vaccines administered in the province to 545,459.

The 8,415 doses of COVID-19 vaccine reported today were administered to residents living in the following zones: Far North West, 312; Far North East, 125; North West, 793; North Central, 427; North East, 315; Saskatoon, 1,404; Central West, 468; Central East, 484; Regina, 1,832; South West, 452; South Central, 538; and South East, 983. There were 282 doses administered with zone of residence pending.

Seventy-two per cent of those over the age of 40 have received their first dose. Sixty-two per cent of those 30+ have received their first dose. Fifty-three per cent of those 18+ have received their first dose.